143 related articles for article (PubMed ID: 19910334)
1. Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy.
Blaauw B; Agatea L; Toniolo L; Canato M; Quarta M; Dyar KA; Danieli-Betto D; Betto R; Schiaffino S; Reggiani C
J Appl Physiol (1985); 2010 Jan; 108(1):105-11. PubMed ID: 19910334
[TBL] [Abstract][Full Text] [Related]
2. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
[TBL] [Abstract][Full Text] [Related]
3. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
Martin PT; Xu R; Rodino-Klapac LR; Oglesbay E; Camboni M; Montgomery CL; Shontz K; Chicoine LG; Clark KR; Sahenk Z; Mendell JR; Janssen PM
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C476-88. PubMed ID: 19109526
[TBL] [Abstract][Full Text] [Related]
5. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
6. Loss of α-actinin-3 confers protection from eccentric contraction damage in fast-twitch EDL muscles from aged mdx dystrophic mice by reducing pathological fibre branching.
Kiriaev L; Houweling PJ; North KN; Head SI
Hum Mol Genet; 2022 May; 31(9):1417-1429. PubMed ID: 34761268
[TBL] [Abstract][Full Text] [Related]
7. Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction.
Call JA; Eckhoff MD; Baltgalvis KA; Warren GL; Lowe DA
J Appl Physiol (1985); 2011 Dec; 111(6):1768-77. PubMed ID: 21960659
[TBL] [Abstract][Full Text] [Related]
8. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions.
Chan S; Head SI; Morley JW
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C985-92. PubMed ID: 17567750
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
[TBL] [Abstract][Full Text] [Related]
10. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
[TBL] [Abstract][Full Text] [Related]
11. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
[TBL] [Abstract][Full Text] [Related]
12. Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.
Call JA; Warren GL; Verma M; Lowe DA
J Physiol; 2013 Aug; 591(15):3765-76. PubMed ID: 23753524
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of alpha-sarcoglycan differently affects fast- and slow-twitch skeletal muscles.
Danieli-Betto D; Esposito A; Germinario E; Sandonà D; Martinello T; Jakubiec-Puka A; Biral D; Betto R
Am J Physiol Regul Integr Comp Physiol; 2005 Nov; 289(5):R1328-37. PubMed ID: 16002556
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
Roy P; Rau F; Ochala J; Messéant J; Fraysse B; Lainé J; Agbulut O; Butler-Browne G; Furling D; Ferry A
Skelet Muscle; 2016; 6():23. PubMed ID: 27441081
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of weakness in Mdx muscle following in vivo eccentric contractions.
Baumann CW; Ingalls CP; Lowe DA
J Muscle Res Cell Motil; 2022 Jun; 43(2):63-72. PubMed ID: 35445349
[TBL] [Abstract][Full Text] [Related]
17. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
18. Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice.
Lynch GS; Rafael JA; Chamberlain JS; Faulkner JA
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1290-4. PubMed ID: 11003610
[TBL] [Abstract][Full Text] [Related]
19. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo.
Cassano M; Dellavalle A; Tedesco FS; Quattrocelli M; Crippa S; Ronzoni F; Salvade A; Berardi E; Torrente Y; Cossu G; Sampaolesi M
Development; 2011 Oct; 138(20):4523-33. PubMed ID: 21903674
[TBL] [Abstract][Full Text] [Related]
20. Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.
Olthoff JT; Lindsay A; Abo-Zahrah R; Baltgalvis KA; Patrinostro X; Belanto JJ; Yu DY; Perrin BJ; Garry DJ; Rodney GG; Lowe DA; Ervasti JM
Nat Commun; 2018 Nov; 9(1):5104. PubMed ID: 30504831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
